- Home
- HAS vs CORT Comparison
HAS vs CORT Comparison
Compare HAS & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HAS
- CORT
- Stock Information
- Founded
- HAS 1923
- CORT 1998
- Country
- HAS United States
- CORT United States
- Employees
- HAS N/A
- CORT N/A
- Industry
- HAS Recreational Games/Products/Toys
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- HAS Consumer Discretionary
- CORT Health Care
- Exchange
- HAS Nasdaq
- CORT Nasdaq
- Market Cap
- HAS 11.5B
- CORT 7.6B
- IPO Year
- HAS N/A
- CORT N/A
- Fundamental
- Price
- HAS $73.92
- CORT $75.18
- Analyst Decision
- HAS Strong Buy
- CORT Strong Buy
- Analyst Count
- HAS 11
- CORT 4
- Target Price
- HAS $85.45
- CORT $139.00
- AVG Volume (30 Days)
- HAS 1.3M
- CORT 675.5K
- Earning Date
- HAS 10-23-2025
- CORT 10-29-2025
- Dividend Yield
- HAS 3.76%
- CORT N/A
- EPS Growth
- HAS N/A
- CORT N/A
- EPS
- HAS N/A
- CORT 1.11
- Revenue
- HAS $4,250,800,000.00
- CORT $716,080,000.00
- Revenue This Year
- HAS $7.56
- CORT $30.62
- Revenue Next Year
- HAS $4.81
- CORT $37.68
- P/E Ratio
- HAS N/A
- CORT $67.23
- Revenue Growth
- HAS N/A
- CORT 25.71
- 52 Week Low
- HAS $49.00
- CORT $38.68
- 52 Week High
- HAS $82.19
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- HAS 33.69
- CORT 60.68
- Support Level
- HAS $77.13
- CORT $69.03
- Resistance Level
- HAS $80.11
- CORT $74.79
- Average True Range (ATR)
- HAS 1.69
- CORT 2.69
- MACD
- HAS -0.84
- CORT 0.32
- Stochastic Oscillator
- HAS 2.18
- CORT 95.68
About HAS Hasbro Inc.
Hasbro is a branded play company providing children and families around the world with entertainment offerings based on a world-class brand portfolio. From toys and games to television programming, motion pictures, and a licensing program, Hasbro reaches customers by leveraging its well-known brands such as Transformers, Nerf, and Magic: The Gathering. The firm acquired EOne in 2019, bolting on popular family properties like Peppa Pig and PJ Masks, and since has divested noncore lines from the tie-up. Furthermore, the addition of Dungeons & Dragons Beyond in 2022, offers the firm access to 19 million digital tabletop players.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.